RAD Ann: RAD receives approval for Phase 1 therapeutic study of NSCLC - 9th Oct 2023, 9:35am

annb0t

annb0t

Top 20
RAD Ann: RAD receives approval for Phase 1 therapeutic study of NSCLC
Price Sensitive: Y
Date: 9th Oct 2023, 9:35am

>>> Read announcement: Google: RAD Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
RAD Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 31st Oct 2023, 10:27am
Replies
0
Views
92
annb0t
annb0t
annb0t
RAD Ann: Entitlement Offer cleansing notice under section 708AA - 31st Oct 2023, 10:20am
Replies
0
Views
82
annb0t
annb0t
annb0t
RAD Ann: Proposed issue of securities - RAD - 31st Oct 2023, 9:54am
Replies
0
Views
60
annb0t
annb0t
annb0t
RAD Ann: Investor webinar - 31st Oct 2023, 9:36am
Replies
0
Views
65
annb0t
annb0t
annb0t
RAD Ann: Proposed issue of securities - RAD - 31st Oct 2023, 9:26am
Replies
0
Views
66
annb0t
annb0t
Top Bottom